Corrective Assignment to Correct the Name of Assignee Previously Recorded on Reel 043894 Frame 0343. Assignor(S) Hereby Confirms the Assignment to Luc Therapeutics, Inc..

Recorded: 2018-03-12 Pages: 14

Assignors

ANDERSON, DAVID R.

Executed: 2016-03-22

VOLKMANN, ROBERT A.

Executed: 2016-03-22

Assignee

LUC THERAPEUTICS, INC.

400 TECHNOLOGY SQUARE, 10TH FLOOR, CAMBRIDGE, MASSACHUSETTS, 02139

Covered Property (1)

N-Arylmethyl Sulfonamide Negative Modulators of NR2A

Patent: 9,963,434 →

Application: 15/024,870 →

Publication: US 2016/0311782

Related Assignments (3)

Other recorded transfers of the patent in this record — the chain of ownership.